These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26611269)

  • 1. What is new in MS spasticity research? Poster session highlights.
    Kappos L; Fazekas F
    Neurodegener Dis Manag; 2015; 5(6 Suppl):27-30. PubMed ID: 26611269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is new in multiple sclerosis spasticity research? Poster session highlights.
    Ghezzi A
    Neurodegener Dis Manag; 2016 Dec; 6(6s):45-47. PubMed ID: 27874498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis spasticity epidemiology--key publications.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):45-6. PubMed ID: 24289842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Country break-out session highlights.
    Fazekas F; Gehring K; Gallo P; Lebrun-Frénay C; Moral E; Myhr KM
    Neurodegener Dis Manag; 2015; 5(6 Suppl):31-7. PubMed ID: 26611270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in multiple sclerosis spasticity research? Poster session highlights.
    Linker R
    Neurodegener Dis Manag; 2017 Nov; 7(6s):51-53. PubMed ID: 29143588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.
    Trojano M; Celius EG; Donzé C; Izquierdo G; Patti F; Pöhlau D
    Eur Neurol; 2014; 72 Suppl 1():15-9. PubMed ID: 25278119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Country breakout session highlights.
    Ghezzi A; Filli L; Solaro C; Mekies C; Landete L; Lycke J
    Neurodegener Dis Manag; 2016 Dec; 6(6s):41-44. PubMed ID: 27874497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology and clinical assessment of spasticity in multiple sclerosis].
    Bensmail D; Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S45-50. PubMed ID: 22721364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing specific symptoms in people with multiple sclerosis.
    Henze T
    Int MS J; 2005 Aug; 12(2):60-8. PubMed ID: 16417816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Break-out session highlights.
    Myhr KM; Mäurer M; Ginés MM; Esposito F; Linker R
    Neurodegener Dis Manag; 2017 Nov; 7(6s):45-49. PubMed ID: 29143586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.
    Oreja-Guevara C
    Expert Rev Neurother; 2012 Apr; 12(4 Suppl):3-8. PubMed ID: 22509985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into multiple sclerosis and advances in multiple sclerosis spasticity management.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):1-2. PubMed ID: 24289835
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of MS spasticity.
    Pozzilli C
    Eur Neurol; 2014; 71 Suppl 1():1-3. PubMed ID: 24457845
    [No Abstract]   [Full Text] [Related]  

  • 16. Spasticity in multiple sclerosis: results of a patient survey.
    Oreja-Guevara C; González-Segura D; Vila C
    Int J Neurosci; 2013 Jun; 123(6):400-8. PubMed ID: 23297730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the management of MS symptoms: recently proposed clinical management algorithms.
    Vermersch P
    Neurodegener Dis Manag; 2015; 5(6 Suppl):23-6. PubMed ID: 26611268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.
    Koehler J; Amato MP; Oreja-Guevara C; Lycke J
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):61-6. PubMed ID: 24289846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Editorial. Spasticity in multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S35. PubMed ID: 22721362
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
    Meuth SG; Vila C; Dechant KL
    Expert Rev Neurother; 2015; 15(8):909-18. PubMed ID: 26166264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.